A recent Harris Survey in the US concluded that 60% of adults are either not confident at all or not very confident that drug makers will publicly and in a timely manner disclose data on their products’ adverse effects. Their skepticism is hardly groundless: internal documents obtained in recent lawsuits reveal that drug companies often fail to submit critical safety information to regulatory agencies, as required by law, and fail to communicate such information to physicians and patients.